Skip to content

Clinical trials

Phase 3 Bipolar Disorder trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Country / region: Bulgaria Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20061
20122
20131
20141
20163
20171
20201
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Intra-Cellular Therapies, Inc.5
Sumitomo Pharma America, Inc.3
AstraZeneca2
Forest Laboratories2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Bristol-Myers Squibb1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Takeda1
Xenon Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder18
Mania2
Autistic Disorder1
Major Depressive Disorder1
Schizophrenia1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.